ALK-ABELLÓ A/S: Financial statements 2017
CVR: 63717916
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ALK-ABELLÓ A/S (CVR 63717916) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 2,910,000,000 and a net result of DKK -158,000,000 compared with DKK 270,000,000 the year before. That is a decrease of 3.2% compared with the year before. The profit margin was -5.4%. Equity in the 2017 report amounted to DKK 3,290,000,000. The solvency ratio was 66.4%.
- Revenue
- DKK 2,910,000,000
- Gross Profit
- DKK 1,642,000,000
- Profit/Loss
- DKK -158,000,000
- Equity
- DKK 3,290,000,000
- Total Assets
- DKK 4,958,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 2.9 mia. | 1.6 mia. | -158 mio. | 3.3 mia. | - |
| 2016 | 3 mia. | 2 mia. | 270 mio. | 2.9 mia. | - |
| 2015 | 2.6 mia. | 1.7 mia. | 344 mio. | 2.7 mia. | - |
| 2014 | 2.4 mia. | 1.7 mia. | 181 mio. | 2.4 mia. | - |
Official annual report
Keep an eye on ALK-ABELLÓ A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 31, 2017, Flemming Pedersen has stepped down as director of ALK-ABELLÓ A/S.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2017 to September 30, 2017.
As of November 29, 2017, Helle Skov Wagner has stepped down as director of ALK-ABELLÓ A/S.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2017 to June 30, 2017.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2017 to March 31, 2017.
ALK-ABELLÓ A/S has published its annual report for 2016. Revenue came to DKK 3,005,000,000, and the net result was DKK 270,000,000.
As of January 1, 2017, Carsten Hellmann is registered as adm. dir. of ALK-ABELLÓ A/S.
About ALK-ABELLÓ A/S
ALK-ABELLÓ A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1961. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ALK A/S and ALLERGOLOGISK LABORATORIUM A/S. The management consists of Peter Halling and Claus Steensen Sølje. The board consists of Anders Hedegaard (chair), Lene Skole-Sørensen, Alan Main and Bertil Erik Lindmark. The company is owned by LUNDBECKFOND INVEST A/S. The company has 1,009 employees (2026). In 2025, the company reported revenue of DKK 6,312,000,000 and a net result of DKK 1,197,000,000 compared with DKK 815,000,000 the year before. Equity in the 2025 report amounted to DKK 6,445,000,000.
